Checkpoint Inhibitors: Managing Immune-Mediated Side Effects

Access Course

 

890963.jpg?interpolation=lanczos-none&resize=300:*Follow the cases of 2 patients who developed immune-related adverse events following treatment with immune checkpoint blockade.

 

This activity is intended for oncologists, emergency medicine physicians, pulmonologists, and nurses.

 

The goal of this activity is to review strategies for identifying and managing adverse events associated with treatment with immune checkpoint blockade.

 

 

Approximate Time to Complete: 30 minutes

 

Credit Available: Feb. 28, 2018 - Feb. 28, 2019

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png      Medscape_EDU-RGB-2x-300.png
Course Objectives
Upon completion of this activity, participants will be able to:
  • Counsel patients on how to communicate with clinicians if they suspect an immune-related adverse effect may be caused by ongoing treatment with an immune checkpoint inhibitor
  • Identify appropriate treatment strategies to manage immune-related adverse events associated with immune checkpoint inhibitors
  • Identify the symptoms of immune-related adverse effects
Accreditation Council For Continuing Medical Education
AMA PRA Category 1 Credit(s)™: 0.50
American Board of Internal Medicine
ABIM MOC Part 2 Credits: 0.50
American Nurses Credentialing Center's Commission on Accreditation
Contact Hour: 0.50